sunitinib
Study Reports Long-Term Data for Nivolumab Plus Cabozantinib in Advanced RCC
Nivolumab plus cabozantinib outperforms sunitinib for first-line treatment of advanced clear cell renal cell ...
MARCH 22, 2023
Peri-Nephrectomy Sunitinib Safe, Effective in mRCC Patients
Sunitinib is safe and as effective as neoadjuvant and adjuvant treatment for patients with metastatic renal cell ...
OCTOBER 19, 2017
Cabozantinib Improves PFS in Advanced RCC
Cabozantinib can improve PFS in patients with previously untreated advanced or metastatic RCC, according to updated ...
SEPTEMBER 21, 2017
Nivolumab-Ipilimumab Combo Beneficial in Advanced RCC
The combination of nivolumab and ipilimumab improved OS over sunitinib in patients with previously untreated ...
SEPTEMBER 20, 2017
Alternate Sunitinib Schedule Is Feasible for mRCC
Although an alternate schedule of sunitinib in patients with mRCC failed to reduce grade 3 or higher toxicity ...
JULY 18, 2017
Individualized Sunitinib Dosing Provides Better Fit
Customized dosing of first-line sunitinib is safe and feasible, providing better response rates and survival in ...
JUNE 27, 2017
2/1 Sunitinib Dosing Schedule Shows Greater Benefits in mRCC
An alternative 2/1 dosing schedule of sunitinib may improve tolerability, reduce the number of dosing changes ...
JUNE 1, 2017
Sorafenib and Sunitinib Similar to Placebo in High-Risk RCC Patients
Neither sorafenib nor sunitinib appeared to be more effective than placebo at improving disease-free survival in ...
APRIL 13, 2017
Some Pts Benefit From Sunitinib Dose Escalation
Patients with mRCC who have disease progression on the standard dose of sunitinib may experience response with a ...
MARCH 7, 2017
Report From ESMO 2016 Congress: After Nephrectomy for RCC, Sunitinib Prolongs DFS
Copenhagen, Denmark—A year of sunitinib therapy after nephrectomy increases disease-free survival (DFS) by ...
DECEMBER 28, 2016
Adjuvant Sorafenib, Sunitinib Don’t Prevent RCC Recurrence
In resected local kidney cancer at high risk for recurrence, sorafenib or sunitinib did not increase survival
MAY 24, 2016